*Choose one option that best fits your usage (there might be more than 1 correct answer). A pharmacist might contact you if the medication is potentially not suitable for your use
IMPORTANT
If you are uncertain or need more assistance about this product, kindly chat with our pharmacist using the on page chat button before purchasing. A pharmacist will be available between 9am-6pm on Mondays - Saturdays
Important Information For Your Reference
Common side effects include: skin redness, burning/ irritation of the skin, skin thinning. For a full list of information
Side Effects:
Do not take this if you are allergic to the medicine or its composition. If you're unsure, check with us or your doctor.
Severe allergic reactions such as severe rash, severe itchiness and fever, swollen throat, face, eyelids or lips can happen. Stop taking this medication and speak to your doctor immediately if you experience these symptoms. This reaction may start soon after you first take the medicine, or it might start later.
Other important information for pregnant women/children/elderly users, please
Alcohol Warning(Safe)
As Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g is used topically, the risk of interacting with alcohol consumed is negligible.There is no known interaction of Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g topical with alcohol.There is no known interaction between alcohol and topical Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g when used concomitantly.
Pregnancy Warning(Not Safe)
Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g may be unsafe to use during pregnancy. Animal reproduction studies have shown adverse effects on the fetus. However, there are limited well-controlled human studies. The benefits from the use of Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g in pregnant women may be acceptable despite the risk. Please consult your doctor. Topical Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g maybe used during pregnancy. Animal reproduction studies do not demonstrate adverse effects on fetus with the use of topical Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g, and there are no adequate studies in pregnant women. This medication should only be used after the benefits and risks have been weighed properly. Please consult the doctor before using Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g.Topical use Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g is absorbed slightly into the system and the safety of the use of Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g has not been established in pregnant women. Thus, it is not advisable to be used during pregnancy. Please consult your doctor.
Breastfeeding Warning(Limited Data)
Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g is probably unsafe to use during lactation. Animals studies showed Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g is excreted in the milk of rats. Limited human data suggests that Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g does not represent a significant risk to the baby. Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g is probably safe to use during lactation. Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g passes into breast milk, but risk of an adverse effect on the infant seems unlikely with therapeutic doses. There are no data on the excretion of Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g in breast milk. Caution should be exercised when using Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g. Please consult your doctor.Excretion of Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g is not known in human breast milk. Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g should not be applied to the breast area during breastfeeding.
Driving Warning (Generally Safe)
Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g should not affect alertness or driving ability. Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g should not affect alertness or driving ability. Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g should not affect alertness or driving ability.
Kidney Warning(Use With Care)
Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g is safe to be used in patients with kidney impairment. The effect of Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g on the kidney is not known. However, it is safer to use with caution and consult a doctor before using this medication. Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g is contraindicated in patients with severe kidney impairment.
Liver Warning(Limited Data)
Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g is generally safe for patients with liver disease. Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g should be used with caution in patients with liver issues. Dose adjustment of Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g may be needed. Please consult the doctor. Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g is contraindicated in patients with severe liver impairment.
Recommended dosage: <p>Adult: Apply thin layer to the affected area once daily for upto 4 weeks (scalp area) or 8 weeks (non-scalp area).</p> <p>Not recommended for children under 18 years.</p>
We ensure that all our pharmaceutical products including health supplements and traditional preparations are registered with the National Pharmaceutical Regulatory Authority (NPRA) Malaysia
Free Delivery on orders above RM120
Enjoy free delivery with a minimum spend of RM120 on our platform.
Quantity
Only 76 left - hurry!
Maximum 3 units per Customer
✕
CLOSE
Term & Condition
100% Authentic
We ensure that all our pharmaceutical products including health supplements and traditional preparations are registered with the National Pharmaceutical Regulatory Authority (NPRA) Malaysia
Free Delivery on orders above RM120
Enjoy free delivery with a minimum spend of RM120 on our platform.
As with all medications, you may experience some side effects. Not everyone experiences it. This is not a cause for concern. However, it is so that you are aware of it.
Itchy Skin, Local Skin Burning Or Pain, Allergic Reaction At The Site Of Application, Worsening Of Condition, Application Site Irritation, Redness, Rash Or Hives, If You Have Psoriasis You May Get Raised Bumps With Pus Under The Skin. This Can Happen Very Rarely During Or After Treatment And Is Known As Pustular Psoriasis Skin Infection.
Skin Irritation/Discomfort, Tingling Sensation
Worsening Of Your Psoriasis, Dermatitis, Redness, Flaking Skin, Burning Feeling Or Irritation, Itching Skin, Rash And Infection Around A Hair Root, Rash, Dry Skin, Changes In Your Skin Colour.
Warning Precautions
Alcohol Warning (Safe)
As Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g is used topically, the risk of interacting with alcohol consumed is negligible.There is no known interaction of Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g topical with alcohol.There is no known interaction between alcohol and topical Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g when used concomitantly.
Pregnancy Warning (Not Safe)
Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g may be unsafe to use during pregnancy. Animal reproduction studies have shown adverse effects on the fetus. However, there are limited well-controlled human studies. The benefits from the use of Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g in pregnant women may be acceptable despite the risk. Please consult your doctor. Topical Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g maybe used during pregnancy. Animal reproduction studies do not demonstrate adverse effects on fetus with the use of topical Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g, and there are no adequate studies in pregnant women. This medication should only be used after the benefits and risks have been weighed properly. Please consult the doctor before using Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g.Topical use Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g is absorbed slightly into the system and the safety of the use of Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g has not been established in pregnant women. Thus, it is not advisable to be used during pregnancy. Please consult your doctor.
Breastfeeding Warning (Limited Data)
Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g is probably unsafe to use during lactation. Animals studies showed Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g is excreted in the milk of rats. Limited human data suggests that Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g does not represent a significant risk to the baby. Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g is probably safe to use during lactation. Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g passes into breast milk, but risk of an adverse effect on the infant seems unlikely with therapeutic doses. There are no data on the excretion of Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g in breast milk. Caution should be exercised when using Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g. Please consult your doctor.Excretion of Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g is not known in human breast milk. Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g should not be applied to the breast area during breastfeeding.
Driving Warning (Generally Safe)
Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g should not affect alertness or driving ability. Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g should not affect alertness or driving ability. Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g should not affect alertness or driving ability.
Kidney Warning (Use With Care)
Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g is safe to be used in patients with kidney impairment. The effect of Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g on the kidney is not known. However, it is safer to use with caution and consult a doctor before using this medication. Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g is contraindicated in patients with severe kidney impairment.
Liver Warning (Limited Data)
Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g is generally safe for patients with liver disease. Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g should be used with caution in patients with liver issues. Dose adjustment of Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g may be needed. Please consult the doctor. Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g is contraindicated in patients with severe liver impairment.
FAQ
Disclaimer
Information last updated on: Thu Nov 14 2024 11:58:50 GMT+0800 (Malaysia Time) The product images shown are for illustration purposes only and may not be an exact representation of the product.
The content provided on this webpage is to provide information only, to be fully-interpreted by a medical professional, and not intended as a guide to make purchase decisions, or a substitute to advice of a medical professional. Effectiveness and side effects of medication may differ from individual to individual. We do not encourage any customer to self-diagnose and/or self-medicate. Patients should always consult a medical professional before taking or using any medication. The content provided here is non-exhaustive and may not cover all aspects of the medication. Our service should only be used to support the doctor-patient dynamic, not replace it.
The fulfilment of prescription medication is subject to our review of a prescription issued by a Malaysian Medical Council (MMC) registered doctor. If required, we will provide a tele-consult service with one of our registered panel doctors. This is not an advertisement of a medicine as such an advertisement would require prior approval from the Medicines Advertisement Board of Malaysia. Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g is available in many areas in Malaysia. Kuala Lumpur, Bukit Bintang, Titiwangsa, Setiawangsa, Wangsa Maju, Kepong, Segambut, Bandar Tun Razak, Cheras, Subang Jaya, Petaling Jaya, Mont Kiara, Puchong, Bandar Sunway, TTDI, Seri Kembangan, Klang, Bukit Tinggi, Damansara, Sentul, Penang, George Town, Jelutong, Gelugor, Bayan Baru, Bandar Baru Air Itam, Sungai Ara, Bukit Mertajam, Butterworth, Perai, Johor Bahru, Skudai, Bukit Indah, Gelang Patah, Senai, Pasir Gudang, Taman Daya, Taman Molek, Taman Perling, Tebrau, Danga Bay, Larkin, Nusajaya, Pontian, Masai, Setia Tropika, Desaru, Tampoi.
Enstilar (50 mcg/g + 0.5 mg/g) Cutaneous Foam 60g is available at many places in Singapore. Ang Mo Kio, Alexandra, Admiralty, Bedok, Bishan, Bukit Batok, Bukit Merah, Bukit Panjang, Bukit Timah, Boat Quay, Buona Vista, Beach Road, Bugis, Balestier, Boon Lay, Central Area, Choa Chu Kang, Clementi, Chinatown, Commonwealt, City Hall, Clarke Quay, Changi Airport, Changi Village, Clementi Park, Dairy Farm, Eunos, East Coast, Farrer Park, Geylang, Hougang, Harbourfront, Holland, Jurong, Jurong East, Jurong West, Kallang/ Whampoa, Lim Chu Kang, Marine Parade, Marina, Macpherson, Mandai, Newton, Novena, Orchard, Pasir Ris, Punggol, Potong Pasir, Paya Lebar, Queenstown, Raffles Place, Rochor, River Valley, Sembawang, Sengkang, Serangoon, Serangoon Rd, Seletar, Tampines, Toa Payoh, Tanjong Pagar, Telok Blangah, Tanglin, Thomson, Tuas, Tengah, Upper East Coast, Upper Bukit Timah, Upper Thomson, Woodlands, West Coast, Yishun, Yio Chu Kang.
